The approval is based on results from the Phase III FLOW trial demonstrating Ozempic reduced the risk of severe kidney outcomes by 24% compared to placebo, including kidney failure, reduction in ...

The new indication makes Ozempic the first glucagon-like peptide-1 receptor agonist (GLP-1RA) available for people with T2D ...

Smartphones are taking a shot at slenderizing in a nod to Ben Stiller’s itty-bitty mobile in the early-aughts classic ...

SLOWLY lifting her head off her sweat-drenched pillow, Aisleyne Horgan-Wallace vomits into the sick bucket next to her bed. ...

High demand and supply shortages of weight loss drugs have presented opportunities for counterfeit drugs to enter the market.

Oikos and its other popular brands are seeing a spike in demand as people taking the weight-loss medications turn to the ...

The negotiated prices of 15 Medicare Part D drugs, which include several blockbusters, will go into effect in 2027.

Novo sells semaglutide as Ozempic, Rybelsus and Wegovy. The CMS will treat the different forms as a single product in price ...

GLP-1 drug users initially spend less on groceries, but that levels out over the next year, shows Circana's analysis of food purchases.

Lately, there has been a notable step-up in mainstream media coverage of the potential health risks associated with ultra-processed food (UPF). Two large-scale studies in 2023 presented at the ...

Calum Harris “doesn’t regard himself as a chef”, says Hannah Harley Young, host of the Crazy Sexy Food podcast. Well, good – because he isn’t one. His rise to prominence as a devotee of vegan food was ...

Wegovy and Ozempic have become household names, but how easy are they to get if you don't meet the medical criteria? Sky's Lucy Marley went to find out.